ijms-logo

Journal Browser

Journal Browser

Solid-Phase Peptides: Syntheses and Applications

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: 20 June 2025 | Viewed by 1711

Special Issue Editor


E-Mail Website
Guest Editor
Laboratoire de Chimie Physique Macromoléculaire, Université de Lorraine‐CNRS, 54001 Nancy, France
Interests: organic synthesis; solid phase peptide synthesis; pseudopeptides as self-assembled foldamers; targeted peptides as therapeutic drug delivery systems for biological applications; anticancer photodynamic therapy applications; nuclear medicine applications; neurodegenerative applications; cerebrovascular applications

Special Issue Information

Dear Colleagues,

This Special Issue of International Journal of Molecular Sciences is dedicated to “Solid-Phase Peptides: Syntheses and Applications”. Peptides are small proteins made up of amino acid sequences (i.e., up to 50–100 amino acids) attached to each other with peptide bonds. Natural peptides play a pivotal role in all living organisms owing to their participation in nearly all physiological processes. One century since the discovery of the insulin peptide for diabetes treatment, the interest generated by the natural and synthetic peptides as therapeutic drugs for various disease treatments (e.g., cancer, cardiovascular, neurogenerative, etc.) has steadily increased.

Broadly speaking, in peptide synthesis, the repeated purification steps after each amino acid coupling cycle are the most laborious, expensive, and time-consuming steps, which significantly increases the overall synthesis time. Solid-Phase Peptide Synthesis (SPPS) is a powerful technique simplifying and facilitating the synthesis of peptides. SPPS is based on a stepwise construction of peptides from their C-terminus anchored to an insoluble polymer (i.e., resin) through iterative coupling reactions of protected amino acids. The use of resins can dramatically reduce the synthesis time along with an increase in crude purity and yield by replacing the purification steps with simple washing steps of the resin.

Since it was pioneered by Bruce Merrifield in 1963, SPPS has now become a routine technique with continuous modernizations (e.g., Fmoc/tBu approach, automation, microwave assistance, etc.) and largely used by researchers in the development of new therapeutic drugs for various diseases.

This Special Issue will provide an opportunity to publish research results or review articles dedicated to all aspects of Solid-Phase Peptides, focusing on them at a molecular level, and including, but not limited to, peptide–protein interactions, synthesis methodology (e.g., new resins, new coupling reagents, etc.), the isolation of new bioactive peptides from nature, the development of new bioactive synthetic peptides, all peptide-based approaches for disease treatments and/or drug delivery, etc.

Dr. Samir Acherar
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • peptide
  • peptide-based compounds
  • solid-phase synthesis
  • molecular interactions
  • methodology
  • disease treatments
  • drug delivery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

19 pages, 6910 KiB  
Article
Poly(Epsilon-Lysine) Dendrons Inhibit Proliferation in HER2-Overexpressing SKBR3 Breast Cancer Cells at Levels Higher than the Low-Expressing MDA-MB-231 Phenotype and Independently from the Presentation of HER2 Bioligands in Their Structure
by Giordana M. S. Peregrino, Laila Kudsiova and Matteo Santin
Int. J. Mol. Sci. 2024, 25(22), 11987; https://doi.org/10.3390/ijms252211987 - 8 Nov 2024
Viewed by 1046
Abstract
Among the known breast cancers, the subtype with HER2 receptors-overexpressing cells is associated with a poor prognosis. The adopted monoclonal antibody Trastuzumab has improved clinical outcomes, but it is associated with drug resistance and relatively high costs. The present work adopted the peptide [...] Read more.
Among the known breast cancers, the subtype with HER2 receptors-overexpressing cells is associated with a poor prognosis. The adopted monoclonal antibody Trastuzumab has improved clinical outcomes, but it is associated with drug resistance and relatively high costs. The present work adopted the peptide solid-phase synthesis method to synthesise branched poly(ε-lysine) peptide dendrons with 8 branching arms integrating, at their carboxy terminal molecular root, either an arginine or the HER2 receptor-binding sequence LSYCCK or the scramble sequence CSCLYK. These dendrons were synthesised in quantities higher than 100 mg/batch and with a purity exceeding 95%. When tested with two types of breast cancer cells, the dendrons led to levels of inhibition in the HER2 receptor-overexpressing breast cancer cells (SKBR3) comparable to Trastuzumab and higher than breast cancer cells with low receptor expression (MDA-MB-231) where inhibition was more moderate. Noticeably, the presence of the amino acid sequence LSYCCK at the dendron molecular root did not appear to produce any additional inhibitory effect. This was demonstrated also when the scramble sequence CSCLYK was integrated into the dendron and by the lack of any antiproliferative effect by the control linear target sequence. The specific inhibitory effect on proliferation was finally proven by the absence of cytotoxicity and normal expression of the cell migration marker N-Cadherin. Therefore, the present study shows the potential of poly(ε-lysine) dendrons as a cost-effective alternative to Trastuzumab in the treatment of HER2-positive breast cancer. Full article
(This article belongs to the Special Issue Solid-Phase Peptides: Syntheses and Applications)
Show Figures

Figure 1

Back to TopTop